IFN-induced depression: a role for NSAIDs.

Gregory M. Asnis, Richard De la Garza, Shari R. Kohn, John F. Reinus, Margaret Henderson, Johar Shah

Research output: Contribution to journalReview article

32 Scopus citations

Abstract

Interferon-alpha (IFN) is widely used for the treatment of viral illnesses and other chronic diseases, though its usefulness is hampered by a problematic side-effect profile. In particular, IFN-alpha induces neuropsychiatric and neurotoxic side effects, including depression, anxiety, insomnia, lethargy, confusion, and psychosis. Of particular interest, a number of patients develop full psychiatric syndromes, particularly depressive disorders. Recent evidence suggests that conventional antidepressants (especially selective serotonin reuptake inhibitors) are effective in preventing or reducing IFN-induced side-effects, but even these compounds are not 100% effective in preventing these symptoms. As such, alternative treatments must be considered. Non-steroidal anti-inflammatory drugs (NSAIDs) are known to counteract a number of IFN-induced side effects, including cytokine activation, stress hormone release, and neurochemical alterations (reduced 5-HT [serotonin]). NSAIDs are widely recommended for various aspects of flu-like symptoms or sickness behaviors in humans, including those induced specifically by IFN. In addition, NSAIDs appear to be effective in treating premenstrual dysphoric disorder. These data indirectly specify a role for NSAIDs in syndromes with a prominent depression component. Drawing from an extensive pre-clinical and clinical research base, we hypothesize that pretreatment with NSAIDs will not only reduce the incidence of flu-like symptoms, but also prove effective for the prevention or reduction of IFN-induced depression.

Original languageEnglish (US)
Pages (from-to)29-50
Number of pages22
JournalPsychopharmacology bulletin
Volume37
Issue number3
Publication statusPublished - Jan 1 2003

    Fingerprint

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

Asnis, G. M., De la Garza, R., Kohn, S. R., Reinus, J. F., Henderson, M., & Shah, J. (2003). IFN-induced depression: a role for NSAIDs. Psychopharmacology bulletin, 37(3), 29-50.